Bridgepoint sets three targets for RoC Skincare

Antin wins regulatory approval for Opdenergy deal.

21 February 2024•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.